These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1484267)

  • 1. B cell activation and HIV infection: protective or potentially detrimental response?
    Amadori A; Chieco-Bianchi L
    Int Rev Immunol; 1992; 9(1):15-24. PubMed ID: 1484267
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective immunity against HIV infection: lessons from HIV-2 infection.
    Rowland-Jones S
    Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell activation and HIV-1 infection: deeds and misdeeds.
    Amadori A; Chieco-Bianchi L
    Immunol Today; 1990 Oct; 11(10):374-9. PubMed ID: 2103733
    [No Abstract]   [Full Text] [Related]  

  • 4. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
    Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A
    J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
    Cagigi A; Nilsson A; De Milito A; Chiodi F
    Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal patterns in the human immune response to HIV-1 infection.
    Müller S; Nara P; D'Amelio R; Biselli R; Gold D; Wang H; Köhler H; Silverman GJ
    Int Rev Immunol; 1992; 9(1):1-13. PubMed ID: 1484266
    [No Abstract]   [Full Text] [Related]  

  • 7. B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV-1 infection.
    Müller S; Wang H; Silverman GJ; Bramlet G; Haigwood N; Köhler H
    Scand J Immunol; 1993 Oct; 38(4):327-34. PubMed ID: 7692591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytokines and HIV infection].
    Emilie D
    Pathol Biol (Paris); 1993 May; 41(5):449-52. PubMed ID: 8414676
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    Wrin T; Nunberg JH
    AIDS; 1994 Nov; 8(11):1622-3. PubMed ID: 7848602
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apoptosis in HIV infection].
    Maroto Vela Mdel C
    An R Acad Nac Med (Madr); 1994; 111(2):289-311; discussion 311-6. PubMed ID: 7810838
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble factor of transformed B lymphocytes in patients with HIV infection stimulates monocytes to produce PGE2.
    Tarter TH; Cunningham-Rundles S; Laurence J; Koide SS
    Clin Immunol Immunopathol; 1997 Mar; 82(3):303-5. PubMed ID: 9073555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection.
    Lim A; Amini A; D'Orsogna LJ; Rajasuriar R; Kramski M; Lewin SR; Purcell DF; Price P; French MA
    AIDS; 2011 Jul; 25(11):1379-83. PubMed ID: 21572302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.
    Amadori A; Zamarchi R; Ciminale V; Del Mistro A; Siervo S; Alberti A; Colombatti M; Chieco-Bianchi L
    J Immunol; 1989 Oct; 143(7):2146-52. PubMed ID: 2476498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1.
    Bélec L; Kourtis AP
    Adv Exp Med Biol; 2012; 743():139-60. PubMed ID: 22454347
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual Immunity Concomitantly Suppresses HIV-1 Progression.
    Qureshi H; Bhattacharya J
    Trends Microbiol; 2017 May; 25(5):334-335. PubMed ID: 28284876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models for the study of human immunodeficiency virus infections.
    Letvin NL
    Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
    Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
    AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to reverse transcriptase in HIV infection and progression to AIDS.
    Schattner A; Milchan R; Kaminchik J; Yavin Z; Bentwich Z
    Immunol Lett; 1992 Jul; 33(2):207-10. PubMed ID: 1280249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
    Sadanand S; Suscovich TJ; Alter G
    Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis of human immunodeficiency virus.
    Ahsan N; Langhoff E
    Semin Nephrol; 1998 Jul; 18(4):422-35. PubMed ID: 9692354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.